C. Xu
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 84
- Lung Cancer Diagnosis and Treatment 16
- Gastric Cancer Management and Outcomes 7
- Oncology 66
- Lung Cancer Research Studies 24
- Colorectal Cancer Treatments and Studies 17
- Co-authors
- Wenxian Wang (72 shared papers)You‐cai Zhu (42 shared papers)Zhengbo Song (30 shared papers)Kaiqi Du (23 shared papers)Huafei Chen (20 shared papers)Wu Zhuang (34 shared papers)Meiyu Fang (23 shared papers)Yong Song (35 shared papers)
- Journals
- Journal of Thoracic Oncology (27 papers)Journal of Clinical Oncology (14 papers)Lung Cancer (7 papers)Cellular and Molecular Biology (6 papers)OncoTargets and Therapy (5 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
C. Xu
169 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 104
- Pulmonary and Respiratory Medicine 834
- Cancer Research 372
- Oncology 640
- Molecular Biology 490
- Pathology and Forensic Medicine 116
Countries citing papers authored by C. Xu
This map shows the geographic impact of C. Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Xu more than expected).
Fields of papers citing papers by C. Xu
This network shows the impact of papers produced by C. Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Xu. The network helps show where C. Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 86 | |
| 2 | 2017 | 62 | |
| 3 | 2018 | 53 | |
| 4 | 2021 | 51 | |
| 5 | 2018 | 39 | |
| 6 | 2021 | 36 | |
| 7 | 2020 | 35 | |
| 8 | 2021 | 34 | |
| 9 | 2019 | 32 | |
| 10 | 2018 | 32 | |
| 11 | 2022 | 30 | |
| 12 | 2020 | 28 | |
| 13 | 2019 | 28 | |
| 14 | 2016 | 27 | |
| 15 | 2017 | 27 | |
| 16 | 2017 | 27 | |
| 17 | 2019 | 25 | |
| 18 | 2020 | 25 | |
| 19 | 2019 | 24 | |
| 20 | 2022 | 23 |
About C. Xu
C. Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 190 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (84 papers), Lung Cancer Research Studies (24 papers), Cancer Genomics and Diagnostics (22 papers), Colorectal Cancer Treatments and Studies (17 papers), Lung Cancer Diagnosis and Treatment (16 papers), RNA modifications and cancer (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Gastric Cancer Management and Outcomes (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (834 citations), Cancer Research (372 citations), Oncology (640 citations), Molecular Biology (490 citations) and Pathology and Forensic Medicine (116 citations). C. Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Wenxian Wang, You‐cai Zhu, Zhengbo Song, Kaiqi Du, Huafei Chen, Wu Zhuang, Meiyu Fang, Yong Song, Tangfeng Lv and Lixin Wu. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Lung Cancer, Cellular and Molecular Biology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.